Profiting from Pain: Business and the U.S. Opioid Epidemic* Assignment Questions 2. Is there anything that the pharmaceutical industry has done or is now doing in the aftermath of that crisis that could legitimately be considered as unethical by its stakeholders? What grade would you assign to the industry for its handling of the crisis? Explain. 3. In what ways, if any, should the stakeholders in the U.S. opioid crisis bear responsibility? Are there any changes to the industry actors CSR strategy that you would suggest? 4. If some shareholders complained that the pharmaceutical industry has been spending too little or too much effort on corporate social responsibility, what would you tell them?